408 related articles for article (PubMed ID: 11026819)
1. [Childhood acute myeloblastic leukemias. Report of 21 cases].
Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
[TBL] [Abstract][Full Text] [Related]
2. [Factors related to prognosis and relapse in acute myelomonocytic and monocytic leukemias (M4 and M5)].
Koyama A; Shirakawa C; Masaki H; Horiuchi F; Hamazaki H; Fujimoto T; Irimajiri K; Horiuchi A
Rinsho Ketsueki; 1990 Nov; 31(11):1787-93. PubMed ID: 2287062
[TBL] [Abstract][Full Text] [Related]
3. [Acute leukemia in the elderly patient. Forty case reports].
Laatiri MA; Chehata S; Ajmi F; Amouri A; Bouaouina N; Saad A; Ennabli S
Tunis Med; 2000; 78(8-9):503-7. PubMed ID: 11190727
[TBL] [Abstract][Full Text] [Related]
4. [Acute lymphoblastic leukemia in adults. Apropos of 42 cases].
Laatiri MA; Chehata S; Amouri A; Bouaouina N; Gayed C; Saad A; Ennabli S
Tunis Med; 2000 Feb; 78(2):115-9. PubMed ID: 10894047
[TBL] [Abstract][Full Text] [Related]
5. [Remission induction treatment in adults with acute myeloid leukemia. 8-year experience with 2 successive protocols].
del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Krsnik I; Guerra JL; Llorente L; López JC; Díaz Morfa M; Villegas A
Med Clin (Barc); 1989 Apr; 92(16):601-4. PubMed ID: 2747321
[TBL] [Abstract][Full Text] [Related]
6. [Acute myeloblastic leukemia in adults: evaluation of the AML 06/96 protocol].
Qachouh M; Quessar A; Harif M; Benchekroun S
Tunis Med; 2003 Jul; 81(7):461-5. PubMed ID: 14534956
[TBL] [Abstract][Full Text] [Related]
7. Acute non-lymphoblastic leukemia in children: prognostic factors and results of chemotherapy.
Advani SH; Charak BS; Banavali SD; Gopal R; Nair CN; Saikia TK; Pai SK; Kurkure PA; Nadkarni KS; Pai VR
Indian Pediatr; 1990 Jan; 27(1):14-20. PubMed ID: 2361737
[TBL] [Abstract][Full Text] [Related]
8. [Acute lymphoblastic leukemia with Philadelphia chromosome: eight case reports].
Laatiri MA; Chehata S; Amouri A; Sendi HS; Saad A; Ennabli S
Tunis Med; 2001 Jan; 79(1):38-41. PubMed ID: 11332342
[TBL] [Abstract][Full Text] [Related]
9. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
Yavuz S; Paydas S; Disel U; Sahin B
Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
[TBL] [Abstract][Full Text] [Related]
10. Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia.
Hijiya N; Metzger ML; Pounds S; Schmidt JE; Razzouk BI; Rubnitz JE; Howard SC; Nunez CA; Pui CH; Ribeiro RC
Pediatr Blood Cancer; 2005 Jan; 44(1):63-9. PubMed ID: 15368547
[TBL] [Abstract][Full Text] [Related]
11. Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.
Gupta V; Chun K; Yi QL; Minden M; Schuh A; Wells R; Brandwein J
Cancer; 2005 May; 103(10):2082-90. PubMed ID: 15830348
[TBL] [Abstract][Full Text] [Related]
12. Outcome of acute myeloid leukaemia in adults: a retrospective analysis.
Saikia TK; Bakshi A; Bhagwat R; Tawde S; Nair R; Nair CN; Parikh PM
Natl Med J India; 2005; 18(1):12-5. PubMed ID: 15835484
[TBL] [Abstract][Full Text] [Related]
13. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
14. Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.
Liu J; Mi Y; Fu M; Yu W; Wang Y; Lin D; Bian S; Wang J
Am J Hematol; 2009 Jul; 84(7):422-7. PubMed ID: 19484734
[TBL] [Abstract][Full Text] [Related]
15. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Büchner T; Hiddemann W; Berdel WE; Wörmann B; Schoch C; Fonatsch C; Löffler H; Haferlach T; Ludwig WD; Maschmeyer G; Staib P; Aul C; Gruneisen A; Lengfelder E; Frickhofen N; Kern W; Serve HL; Mesters RM; Sauerland MC; Heinecke A;
J Clin Oncol; 2003 Dec; 21(24):4496-504. PubMed ID: 14673036
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of CD7 expression in adult acute myeloid leukemia].
Saito T; Usui N; Dobashi N; Maki N; Asai O; Yano S; Kato A; Watanabe H; Katori M; Nagamine M; Ogihara A; Yamazaki H; Kobayashi T; Tajima N; Kuraishi Y
Rinsho Ketsueki; 1998 Jul; 39(7):481-6. PubMed ID: 9750454
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience.
Romani C; Di Tucci AA; Dessalvi P; Pettinau M; Emanuele A
Am J Hematol; 2010 Mar; 85(3):219. PubMed ID: 20063278
[No Abstract] [Full Text] [Related]
18. [Acute leukemia. Case material and therapeutic results].
Paolino W; Resegotti L; Rossi M; Infelise V; Degani GF
Minerva Med; 1975 May; 66(35):1642-52. PubMed ID: 1055305
[TBL] [Abstract][Full Text] [Related]
19. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloblastic leukemia in adults.
Kasthuri AS; Jaiprakash MP; Anand KP; Kumar R
J Assoc Physicians India; 1995 Feb; 43(2):108-10. PubMed ID: 9282674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
